Suppr超能文献

肾移植受者的肺诺卡菌病:一例病例报告及对60例已发表病例的分析。

Pulmonary nocardiosis in kidney transplant recipients: A case report and analysis of 60 published cases.

作者信息

Dalil Davood, Yaghoubi Fatemeh, Tavakoli Farnaz, Hosseini Seyyed Mohammad, Isakhani Mahdi

机构信息

School of Medicine, Shahed University, Tehran, Iran.

Nephrology Research Center, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

IDCases. 2025 Sep 14;42:e02374. doi: 10.1016/j.idcr.2025.e02374. eCollection 2025.

Abstract

BACKGROUND

Pulmonary nocardiosis (PN) is a rare life-threatening opportunistic infection, particularly involving immunocompromised patients, including kidney transplant recipients (KTRs). This study aimed to present a case of PN in a KTR and review published cases to describe the demographic, clinical, and treatment characteristics of PN in this population.

METHODS AND RESULTS

Here, we report a case of PN in a 68-year-old diabetic patient with a history of kidney transplantation. Upon admission, antimicrobial and antifungal therapy was initiated empirically, considering a chest CT suggestive of fungal infection and pneumonia. In further evaluations, was isolated from bronchoalveolar lavage cultures. After PN diagnosis and tailoring antibiotic regimen to Trimethoprim-sulfamethoxazole (TMP-SMX), the patient showed significant improvement. This study also reviewed the English-language literature published from 1981 to 2023 about PN in KTRs and described various characteristics of 60 similar patients. Moreover, antibiotics and the type of combination therapy used for treatment and outcomes were discussed. The median time of onset of PN after kidney transplantation was 182 days (70.5-730). Lung was the only affected organ by in 37 patients, while in 13 patients, simultaneous involvement of the lungs and the brain was reported. Fever (74.5 %) was the most reported symptom, followed by cough (50.9 %), headache (41.8 %), and dyspnea (30.9 %). TMP-SMX was the most frequently prescribed antibiotic, having been provided in 32 patients (59.3 %). Other antibiotics included carbapenems, cephalosporins, amoxicillin/clavulanic acid, etc. Furthermore, 38 patients (70.4 %) received combination therapy, whereas 16 patients (29.6 %) received a single antibiotic agent. Lastly, the outcomes of 55 patients were reported. While the majority (81.8 %) were successfully treated, 10 patients (18.2 %) expired due to nocardiosis.

CONCLUSION

Physicians should consider the diagnosis of PN in the differential diagnosis of KTR presenting with pneumonia, especially within the first six months post-transplant, when the risk of nocardiosis is elevated due to intensive immunosuppression.

摘要

背景

肺诺卡菌病(PN)是一种罕见的危及生命的机会性感染,尤其易发生于免疫功能低下的患者,包括肾移植受者(KTRs)。本研究旨在报告1例KTR发生PN的病例,并回顾已发表的病例,以描述该人群中PN的人口统计学、临床和治疗特征。

方法与结果

在此,我们报告1例68岁有肾移植病史的糖尿病患者发生PN的病例。入院时,鉴于胸部CT提示真菌感染和肺炎,经验性地开始了抗菌和抗真菌治疗。在进一步评估中,从支气管肺泡灌洗培养物中分离出[具体病原菌未提及]。在诊断为PN并调整抗生素方案为复方磺胺甲恶唑(TMP-SMX)后,患者病情显著改善。本研究还回顾了1981年至2023年发表的关于KTRs中PN的英文文献,并描述了60例类似患者的各种特征。此外,还讨论了用于治疗的抗生素和联合治疗类型及结果。肾移植后PN发病的中位时间为182天(70.5 - 730天)。37例患者中,肺是唯一受[具体病原菌未提及]影响的器官,而13例患者报告肺和脑同时受累。发热(74.5%)是最常报告的症状,其次是咳嗽(50.9%)、头痛(41.8%)和呼吸困难(30.9%)。TMP-SMX是最常处方的抗生素,32例患者(59.3%)使用过。其他抗生素包括碳青霉烯类、头孢菌素类、阿莫西林/克拉维酸等。此外,38例患者(70.4%)接受了联合治疗,而16例患者(29.6%)接受了单一抗生素治疗。最后,报告了55例患者的结局。虽然大多数(81.8%)患者成功治愈,但10例患者(18.2%)因诺卡菌病死亡。

结论

医生在对出现肺炎的KTR进行鉴别诊断时应考虑PN的诊断,尤其是在移植后的前6个月内,此时由于强化免疫抑制,诺卡菌病的风险升高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/028b/12476068/67a661cd3d38/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验